INTEGRATED BIOPHARMA INC Operating Lease Right-of-Use Assets
INTEGRATED BIOPHARMA INC (INBP) had Operating Lease Right-of-Use Assets of $3.20 million as of 2026-03-31, per its 10-Q filed 2026-05-08.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-05-08
- 2026-03-31: Operating Lease, Right-of-Use Asset $3.20M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $366.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $612.00K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $855.00K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-03-31 | $3.20M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $366.00K 10-Q · filed 2026-02-11 |
| 2025-09-30 | $612.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $855.00K 10-Q · filed 2026-05-08 |
| 2025-03-31 | $1.09M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.32M 10-Q · filed 2025-02-13 |
| 2024-09-30 | $1.56M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.79M 10-K · filed 2025-09-23 |
| 2024-03-31 | $2.02M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $2.25M 10-Q · filed 2024-02-12 |
| 2023-09-30 | $2.47M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.62M 10-K · filed 2024-09-20 |
| 2023-03-31 | $2.84M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.05M 10-Q · filed 2023-02-10 |
| 2022-09-30 | $2.65M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.87M 10-K · filed 2023-09-15 |
| 2022-03-31 | $1.99M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.12M 10-Q · filed 2022-02-10 |
| 2021-09-30 | $2.24M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.37M 10-K · filed 2022-09-13 |
| 2021-03-31 | $2.46M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $2.58M 10-Q · filed 2021-02-12 |
| 2020-09-30 | $2.70M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $2.82M 10-K · filed 2021-09-02 |
| 2020-03-31 | $2.94M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $3.05M 10-Q · filed 2020-02-12 |
| 2019-09-30 | $3.17M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $3.28M 10-K · filed 2020-09-23 |
| 2019-03-31 | $3.40M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $3.51M 10-Q · filed 2019-02-13 |
| 2018-09-30 | $3.63M 10-Q · filed 2018-11-09 |